title: Egg yolk phospholipids enriched with 1-O-octadecyl-2-oleoyl-sn-glycero-3-phospho-(N-palmitoyl) ethanolamine inhibit development of experimentally induced tumours.
abstract: Dietary phospholipids (PLs) and their derivatives have proved active in suppression of various health problems and conditions including cancer. In this work we compared the effect of dietary phospholipids from hen egg yolk enriched with N-acyl ether-phosphatidyl ethanolamine (NAEPE) termed bioactive phospholipids (BAP+ preparation) with PLs lacking NAEPE (BAP- preparation) on the growth of transformed cells in vitro and on the promotion and progression of experimental tumours in vivo. For the in vivo experiments we used the chicken model in which liver, lung, and kidney tumours arose via natural selection from single cells initiated by experimentally introduced somatic mutations caused by insertional mutagenesis. Mutagenized animals were fed BAP+ or BAP- diet in various regimens. We observed that BAP+ at low concentrations killed cells of various tumour cell lines in culture but did not compromise viability of non-transformed cells. Oral administration of the BAP+ preparation efficiently reduced progression of all tumour types. However, it did not significantly reduce the number of already initiated tumours and their growth when BAP+ was discontinued. Our data suggest that NAEPE combined with hen egg PLs significantly interferes with tumour progression, possibly through the inhibition of tumour cell viability.
authors: Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
authors: V
authors: V
authors: Karafiát
authors: Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
authors: P
authors: P
authors: Veselý
authors: Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.
authors: M
authors: M
authors: Dvořák
mesh_terms: D000284:Administration, Oral; D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D004195:Disease Models, Animal; D004530:Egg Yolk / Q000737:chemistry*; D004983:Ethanolamines / Q000737:chemistry / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D010743:Phospholipids / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D004983:Ethanolamines; D010743:Phospholipids